Protalix BioTherapeutics (PLX) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.28% |
| Dec 31, 2025 | 4.69% |
| Sep 30, 2025 | 6.59% |
| Jun 30, 2025 | 0.93% |
| Mar 31, 2025 | 1.08% |
| Dec 31, 2024 | 3.27% |
| Sep 30, 2024 | -5.03% |
| Jun 30, 2024 | -12.40% |
| Mar 31, 2024 | -9.81% |
| Dec 31, 2023 | -3.34% |
| Sep 30, 2023 | 0.43% |
| Jun 30, 2023 | -11.21% |
| Mar 31, 2023 | 4.38% |
| Dec 31, 2022 | 15.39% |
| Sep 30, 2022 | 9.07% |
| Jun 30, 2022 | 3.72% |
| Mar 31, 2022 | 7.27% |
| Dec 31, 2021 | 9.23% |
| Sep 30, 2021 | 1.06% |
| Jun 30, 2021 | -7.09% |
| Mar 31, 2021 | -1.10% |
| Dec 31, 2020 | 22.97% |
| Sep 30, 2020 | -3.81% |
| Jun 30, 2020 | 4.14% |
| Mar 31, 2020 | 5.22% |
| Dec 31, 2019 | 20.14% |
| Mar 31, 2019 | 17.13% |
| Dec 31, 2018 | 15.24% |
| Sep 30, 2018 | 14.46% |
| Jun 30, 2018 | 3.08% |
| Mar 31, 2018 | 0.26% |
| Dec 31, 2017 | 0.34% |
| Sep 30, 2017 | 7.79% |
| Jun 30, 2017 | 10.24% |
| Mar 31, 2017 | -1.04% |
| Dec 31, 2016 | -18.57% |
| Sep 30, 2016 | -8.23% |
| Jun 30, 2016 | -4.40% |
| Mar 31, 2016 | -5.83% |
| Dec 31, 2015 | -16.30% |
| Sep 30, 2015 | 5.06% |
| Jun 30, 2015 | 4.68% |